Tweets
How does cMRI change over time in cardiac EGPA?
Cheng et al. retrospectively reviewed:
- 11 EGPA pt with LGE on initial cMRI
Despite treatment:
- 10/11 persistent LGE on 2nd cMRI
- 4/4 on 3rd
- 2/2 on 4th
Unclear use as a monitor of tx response
@RheumNow #ACR25
Brian Jaros, MD @Dr_Brian_MD ( View Tweet )
1 week 1 day ago
#0773 Anti-MDA5 epitope mapping identifies key regions (aa 201-300, 601-700) linked to treatment resistance & poor prognosis in DM-ILD and even IIPs.
Epitope-specific antibodies could refine risk stratification & guide therapy in ILD beyond autoimmune disease. @RheumNow #ACR25 https://t.co/moRffVGZPn
Mrinalini Dey @DrMiniDey ( View Tweet )
1 week 2 days ago
#ACR25 Abstr#0772. Should we be worried of #SLE patients with low uPCR 0.25-0.49? Kidney biopsy in N=28 + poor prognostic (Non-White, active serology or active sediment)
- 71% had LN (No class IV or Mixed)
- 46% actionable LN
Cost-effectiveness data needed.
#ACRBest @RheumNow https://t.co/Bt3fuA3aJh
Links:
Md Yuzaiful Md Yusof @Yuz6Yusof ( View Tweet )
1 week 2 days ago
Organ Specific Recommendations-ACR guidelines for Management of SLE by Dr Lisa Sammaritano. @RheumNow #ACR2025 https://t.co/ilKWG8CQbe
Dr M Nazibur Rahman, MD (Rheumatology) @NaziburM ( View Tweet )
1 week 2 days ago
AI-enhanced MRI integrating STIR and T1-weighted MRI with BME data reflecting both inflammatory and structural changes, enabling the AI model to predict clinical diagnoses of axSpA with accuracy of 82%. Successfully identified axSpA patients who did not meet the ASAS criteria for https://t.co/dLlGj0ZFpj
Antoni Chan MD (Prof) @synovialjoints ( View Tweet )
1 week 2 days ago
Join us at 5pm CST for Day 1 #ACR25 recap! https://t.co/EwZSiPhysF
Dr. John Cush @RheumNow ( View Tweet )
1 week 2 days ago
Plenary session at #ACR25!
#0772 When should we biopsy in SLE?
In pts with uPCR 0.25-0.49 g/g + LN predictors, 69% already had LN (many Class III/V). Low C3/C4 were most important factors.
0.5 g/g cutoff may delay diagnosis and treatment. Time to rethink thresholds? @RheumNow
Mrinalini Dey @DrMiniDey ( View Tweet )
1 week 2 days ago
#LLM can be #virtual #tutor for
đŸ‘‡
#OSCE
RCT - better competence &confidence
#AI & #medical #education
AI trained to #tutor
Also grading OSCE #AI + human
@RheumNow @ACRheum #26S17 https://t.co/CzKoxyjpY8
Janet Pope @Janetbirdope ( View Tweet )
1 week 2 days ago
Early, low level proteinuria is a harbinger in SLE. ~50% with elevated UPCR but <0.5 had actionable LN on early bx.
Risk factor = low c3/c4
Urine biomarkers promising
#ACRBest #ACR25 @RheumNow https://t.co/WuNPKeqeid
Links:
Brian Jaros, MD @Dr_Brian_MD ( View Tweet )
1 week 2 days ago
#Pros and #cons of #AI
Need to know both
Need to assess AI #quality and #accuracy
‘Assume AI WILL be used’
JHausmann
By trainees, patients and medical personnel
Train #faculty re #AI
#ACR25 @RheumNow @ACRheum
#26S17 https://t.co/CvPDQPbueW
Janet Pope @Janetbirdope ( View Tweet )
1 week 2 days ago
What's new in the Pre-RA world?
Slowly unraveling mechanisms and biology associated to transition from CCP+ asymptomatic pre-RA state to clinical RA
Here is my summary of a few abstracts presented at #ACR25 proposing biomarkers beyond the realm of clinical and classical
Aurelie Najm @AurelieRheumo ( View Tweet )
1 week 2 days ago
From Dr. Petri at Plenary - even small amounts of proteinuria are a PROBLEM. Reduction of microalbuminuria by even 10% improves mortality! #ACR25 @RheumNow https://t.co/hjmH26vXIb
Brian Jaros, MD @Dr_Brian_MD ( View Tweet )
1 week 2 days ago
